Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Takeda Pharmaceutical Company Limited (NYSE: TAK)
TAK Stock Predictions and Ratings
WSX Rating:
BUY
WSX Forecast (1yr):
14.60%
Analyst Rating:
NOT AVAILABLE
Analyst Forecast (1yr):
NOT AVAILABLE
TAK Stock Analysis
TAK
PE Ratio:
40.1
TAK
PEG Ratio:
1.6
TAK
Forward EPS Growth (12 month):
24.40%
TAK
PS Ratio:
1.7
TAK
PSG Ratio:
1.4
TAK
Forward Revenue Growth (12 month):
1.20%
TAK Articles
No data was found